Funder
the Basic Science Research Program through the National Research Foundation of Korea
CHA Bundang Medical Center
a faculty research grant from Yonsei University College of Medicine
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. KDOQI; National Kidney Foundation (2006). KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. American Journal of Kidney Diseases, 47(5 Suppl 3), S11–S145.
2. Babitt, J. L., & Lin, H. Y. (2012). Mechanisms of anemia in CKD. Journal of the American Society of Nephrology, 23(10), 1631–1634.
3. Winearls, C. G., Oliver, D. O., Pippard, M. J., Reid, C., Downing, M. R., & Cotes, P. M. (1986). Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet, 2(8517), 1175–1178.
4. Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987). Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. The New England Journal of Medicine, 316(2), 73–78.
5. Macdougall, I. C. (2001). Present and future strategies in the treatment of renal anaemia. Nephrology, Dialysis, Transplantation, 16(Suppl 5), 50–55.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献